5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
β Scribed by Emilio Bajetta; Lorenza Rimassa; Carlo Carnaghi; Ettore Seregni; Leonardo Ferrari; Maria Di Bartolomeo; Enrico Regalia; Antonio Cassata; Giuseppe Procopio; Luigi Mariani
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 87 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The authors thank the Italian Trials in Medical Oncology (I.T.M.O.) group for their assistance with statistical analysis and preparation of the manuscript.
π SIMILAR VOLUMES
## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv
## BACKGROUND. Locally advanced breast carcinoma is associated with a poor prognosis. With single treatment modalities, i.e., surgery and/or radiation therapy, results have been consistently dismal. However, several earlier reports have indicated improvement in survival with a combined modality ap